Plunkett Research Online: Qualigen Therapeutics Inc

QUALIGEN THERAPEUTICS INC (QLGN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology......



Qualigen Therapeutics Inc
Ticker: QLGN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone:
Fax:
Address: 5857 Owens Avenue
Suite 300
Carlsbad, CA 92008 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Research and Development (R&D) in Engineering, Materials, Aerospace, Health, Pharma and Medical
Contacts Description
Michael PoirierCEO/Chairman of the Board/Director/Founder
Christopher LotzCFO/Chief Accounting Officer/Vice President, Divisional
See More
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology......See More See More

Auditor: Baker Tilly US LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20232022202120202020
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: